Correlation Between Neuropace and AMN Healthcare

Can any of the company-specific risk be diversified away by investing in both Neuropace and AMN Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and AMN Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and AMN Healthcare Services, you can compare the effects of market volatilities on Neuropace and AMN Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of AMN Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and AMN Healthcare.

Diversification Opportunities for Neuropace and AMN Healthcare

0.54

Correlation Coefficient

Neuropace  AMN Healthcare

Very weak diversification

The 3 months correlation between Neuropace and AMN is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and AMN Healthcare Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AMN Healthcare Services and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with AMN Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AMN Healthcare Services has no effect on the direction of Neuropace i.e., Neuropace and AMN Healthcare go up and down completely randomly.

Pair Corralation between Neuropace and AMN Healthcare

Given the investment horizon of 90 days Neuropace is expected to under-perform the AMN Healthcare. In addition to that, Neuropace is 2.13 times more volatile than AMN Healthcare Services. It trades about -0.17 of its total potential returns per unit of risk. AMN Healthcare Services is currently generating about -0.02 per unit of volatility. If you would invest  5,733  in AMN Healthcare Services on March 14, 2024 and sell it today you would lose (361.00) from holding AMN Healthcare Services or give up 6.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  AMN Healthcare Services

Neuropace

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neuropace has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in July 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

AMN Healthcare Services

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AMN Healthcare Services has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy primary indicators, AMN Healthcare is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Neuropace and AMN Healthcare

The main advantage of trading using opposite Neuropace and AMN Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, AMN Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AMN Healthcare will offset losses from the drop in AMN Healthcare's long position.

The idea behind Neuropace and AMN Healthcare Services pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.